DECEMBER
2003
Inside News
Magic Johnson visits California
prison for World AIDS Day
Continuing his commitment
to reaching out to at-risk populations, Earvin "Magic" Johnson visited
California Medical Facility in Vacaville, CA on Dec. 3, 2003. After
a private meeting with the prison's inmate peer educators, Magic spoke
to an appreciative audience of over 600 inmates, recounting his own personal
journey following his diagnosis with HIV in 1991. The audience responded
enthusiastically to Magic's messages concerning testing, treatment,
and prevention. Earlier in the week, the prison was host to Assemblyman
Mark Leno, Senator Gloria Romero, and 35 members of the San Francisco Gay
Men's Chorus. Senator Romero took the opportunity to call upon the CA DOC
to evaluate the feasibility of distributing condoms to inmates.
Study: Long Term Adefovir
in HBeAg Negative Chronic Hepatitis B Results in Significant Virological,
Biochemical, and Histologic Improvement
This study presented from
the Henry Dunant Hospital, Athens, Greece and Gilead Sciences showed that
Adefovir dipivoxil (ADV) 10 mg has demonstrated significant histological,
virological, and biochemical improvement as compared to placebo (PLB) through
48 weeks of therapy in HBeAg positive and HBeAg negative patients. Study
authors concluded that Adefovir for 96 weeks resulted in significant and
continued reduction in HBV DNA and ALT; and additional histologic improvement
beyond that seen at week 48. Discontinuation of ADV resulted in loss of
HBV DNA and ALT suppression and reversion of histologic improvement. Emergence
of adefovir resistance was delayed and infrequent. Adefovir has a distinct
resistance profile from lamivudine.
Marcellin, Patrick et
al. 54th AASLD October 2003 Poster 1156.
Sexual Transmission of
HCV in Heterosexual Monogomous Couples
The aim of this study is
to determine the potential for sexual transmission of HCV among monogamous
heterosexual couples by identifying the factors (sexual and non-sexual)
associated with anti-HCV positivity among partners, and the relatedness
of virus strains among concordant couples. The prevalence of anti-HCV among
sexual partners of persons with HCV was 4% (95% CI: 2.3%-5.7%) but 40%
of partners had discordant types indicating lack of sexual transmission.
The majority of type concordant couples lacked percutaneous risk factors
for HCV, suggesting sex may be the route of transmission but phylogenetic
analysis of viral strains will ultimately determine whether sexual transmission
occurred.
Terrault, NA et al. 54th
AASLD. October 2003 Abstract 716.
Weight Loss and Exercise
Can Improve Fibrosis
Obesity is a risk factor
for the progression of fibrosis in chronic liver diseases such as non-alcoholic
fatty liver disease (NAFLD) and hepatitis C (HCV). The aim of this study
was to investigate the longer-term effect of weight loss on liver biochemistry,
serum insulin levels and quality of life in overweight patients with liver
disease and the effect of subsequent weight maintenance or regain and to
determine factors associated with successful weight maintenance. It was
demonstrated that lifestyle interventions reduced risk factors associated
with progression of liver disease, decreased abnormal liver enzymes, improved
quality of life and in a proportion of patients improved histological features
of liver injury. Importantly, these changes were achievable and sustainable
with relatively small but persistent changes in lifestyle. Treatment of
overweight should form an important component of the management of patients
with chronic liver disease.
Hickman, IJ et al. 54th
AASLD. October 2003 Abstract 716.
Study: Survival of HIV-Infected
Liver Transplant Recipients
With immune function restoration
made possible by HAART (Highly Active Antiretroviral Therapy), a study
from the University of Pittsburgh evaluated 24 HIV positive subjects with
ESLD who were undergoing Orthotopic liver transplantation (OLTX). In contrast
to the finding of past inferior survival observed among HIV-infected transplant
recipients, this study found that successful liver transplantation is possible
for HIV-infected subjects, and that for HIV-infected subjects, post-OLTX
survival with ART is similar to that for HIV negative subjects. Data from
this study provide a scientific rationale to justify that HIV infection
should no longer be considered an absolute contraindication to transplantation,
which is consistent with recent transplantation arguments based on ethical
considerations.
Ragni, MV et al. Journal
of Infectious Diseases 188 (2003) pp. 1412-1420.
RETURN
TO THE TOP OF PAGE |
|
Main
Article: The Management of End Stage
Liver Disease in the Correctional Setting
Editor's
Letter
HCV
101: Dosing of pegylated interferon for the treatment of hepatitis
C infection
Spotlight:
Methicillin-Resistant
Staphylococcus Aureus (MRSA)
Inside
News
Save
the Dates
Related
Resources
CME
Online Exam
ABOUT
HEPP REPORT
HEPP News is published eleven times
a year by the:
HIV and Hepatitis Education
Prison Project
Brown University
Box G-B4
Providence,
Rhode Island 02912
401-277-3651
fax 401-277-3656
heppreport@brown.edu |
|